Beat Steffen

Managing Director Novartis Venture Fund

2021 - Current

Principal Novartis Venture Fund

2015 - 2021

Global Franchise Head Critical Care ai

2014 - 2015

General Manager Serelaxin

2013 - 2014

Assistant to Head of Pharma Division

2011 - 2013

Head Marketing General Medicines

2009 - 2011

Associate Director Valturna

2008 - 2009

Regional Director West CV Specialty Sales

2006 - 2008

Member Board of Directors

2021

SpliceBio is a biotechnology company exploiting Protein Splicing to develop the next generation of gene therapies. Our platform is based on technology developed in the Muir Lab at Princeton University after more than 20 years of pioneering intein and protein engineering research.

Chairman of the Board

2020

Rappta Therapeutics is a late preclinical stage biopharmaceutical company. We are working on a first-in-class series of anti-cancer molecular glues that reactivate a key tumor suppressor, protein phosphatase 2A (PP2A).

Member Board of Directors

2019

Vivet Therapeutics is a clinical-stage emerging biotechnology company developing novel gene therapy treatments for rare, inherited metabolic diseases.

Member Board of Directors

2022

The UZH Life Sciences Fund (LSF) provides early financing for life sciences, biotech and med tech spin-offs whose business ideas are based on intellectual property resulting from research done at the University of Zurich. The aim is to accelerate the development process of such spin-offs in the early phase of their life cycle (when fund raising can be long and/or difficult), and thus accelerate the transfer of UZH research findings into practice, which ultimately benefits patients and the public at large.

Chairman of the Board

2020 - 2022

Member Board of Directors

2017 - 2020

Member Board of Directors

2019 - 2020

Binx Health is creating new categories of healthcare solutions that put on-demand testing where people need it most. With its proprietary, desktop, PCR-based point-of-care testing platforms and consumer digital offerings, Binx is redefining "convenient care" for the modern consumer.

Member Board of Directors

2017 - 2019

A pioneering therapeutic approach harnessing the power of protein aggregation.

Senior Associate

1999 - 2001

Resident in Cardiovascular Surgery

1995 - 1998

Cardiovascular Surgery